Antibody-Free Fluorine-Assisted Metabolic Sequencing of RNA N 4 -Acetylcytidine
Shen Yan,Ziang Lu,Wei Yang,Jinglei Xu,Yafen Wang,Wei Xiong,Rongjie Zhu,Linao Ren,Zhaoxin Chen,Qi Wei,Song-mei Liu,Tian Feng,Bifeng Yuan,Xiaocheng Weng,Yuhao Du,Xiang Zhou
DOI: https://doi.org/10.1021/jacs.3c08483
IF: 15
2023-09-29
Journal of the American Chemical Society
Abstract:<i>N</i><sup>4</sup>-Acetylcytidine (ac<sup>4</sup>C) has been found to affect a variety of cellular and biological processes. For a mechanistic understanding of the roles of ac<sup>4</sup>C in biology and disease, we present an antibody-free, fluorine-assisted metabolic sequencing method to detect RNA ac<sup>4</sup>C, called "FAM-seq". We successfully applied FAM-seq to profile ac<sup>4</sup>C landscapes in human 293T, HeLa, and MDA cell lines in parallel with the reported acRIP-seq method. By comparison with the classic ac<sup>4</sup>C antibody sequencing method, we found that FAM-seq is a convenient and reliable method for transcriptome-wide mapping of ac<sup>4</sup>C. Because this method holds promise for detecting nascent RNA ac<sup>4</sup>C modifications, we further investigated the role of ac<sup>4</sup>C in regulating chemotherapy drug resistance in chronic myeloid leukemia. The results indicated that drug development or combination therapy could be enhanced by appreciating the key role of ac<sup>4</sup>C modification in cancer therapy.
chemistry, multidisciplinary